Mia's Feed
Medical News & Research

Reevaluating NAD⁺ Supplements: Do Low Levels Accelerate Aging?

Reevaluating NAD⁺ Supplements: Do Low Levels Accelerate Aging?

Share this article

2 min read

Recent research challenges the common assumption that declining NAD⁺ levels in skeletal muscle significantly contribute to aging and muscle deterioration. NAD⁺ is a vital molecule involved in cellular energy production and various metabolic processes. Its levels tend to decrease with age, leading many to believe that supplementing with NAD precursors could support healthy aging.

However, a study from the Treebak Group at the University of Copenhagen, published in Cell Metabolism, provides new insights. Researchers found that a reduction of up to 85% in NAD⁺ levels specifically within skeletal muscle did not result in accelerated aging or noticeable decline in overall metabolism in mice. These findings suggest that skeletal muscle can tolerate substantial NAD depletion without impairing function or hastening aging processes.

To arrive at this conclusion, scientists engineered mice with the ability to selectively decrease NAD⁺ in muscle tissue after reaching adulthood. Despite the significant reduction, these mice exhibited normal muscle size, strength, and health indicators, even throughout their lifespan. They experienced only minor metabolic changes during exercise, but overall, their health metrics remained comparable to those of normal mice.

This challenges the prevailing view that increasing NAD⁺ levels via supplementation is a necessary strategy for combating muscle aging or frailty. It prompts a reevaluation of the effectiveness of NAD precursors and other related supplements, suggesting that high NAD⁺ levels in skeletal muscle might not be as crucial for maintaining muscle health and delaying aging as previously thought.

The findings open new avenues for understanding aging mechanisms and emphasize that a focus on skeletal muscle NAD⁺ levels alone may not be sufficient. More research is needed to determine the precise role of NAD⁺ in various tissues and to explore whether other pathways contribute more significantly to the aging process.

Source: https://medicalxpress.com/news/2025-05-trash-supplements-nad-aging.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Maintenance Combination of Lurbinectedin and Atezolizumab Improves Survival in Lung Small Cell Carcinoma

A combination of lurbinectedin and atezolizumab as maintenance therapy significantly improves survival in extensive-stage small cell lung cancer, according to new research presented at ASCO 2025.

New Insights into How Cancer Cells Develop Resistance to CDK4/6 Inhibitors

New research uncovers how cancer cells create a protective microenvironment that leads to resistance against CDK4/6 inhibitors, opening avenues for improved therapies in breast cancer treatment.

FDA Accelerates Drug Approvals for Projects Supporting U.S. National Priorities

The FDA introduces a new fast-track program to streamline drug approvals for treatments that support U.S. health priorities, reducing review times from over a year to just a few months.